Literature DB >> 16316777

Comparison of oral fluid and serum ELISAs in the determination of IgG response to natural human papillomavirus infection in university women.

Farrel J Buchinsky1, Joseph J Carter, Gregory C Wipf, James P Hughes, Laura A Koutsky, Denise A Galloway.   

Abstract

BACKGROUND: Venipuncture (phlebotomy) is an obstacle to subject recruitment and ongoing participation in cohort studies investigating human papillomavirus (HPV) infection. Anti-HPV antibodies are not only detected in serum but also in oral fluid.
OBJECTIVES: To evaluate if oral fluid specimens can be used in lieu of blood specimens for determining HPV antibody status. STUDY
DESIGN: One hundred and seven paired oral fluid and blood specimens from female university students were tested in a HPV16 ELISA and compared to sexual history and serial genital HPV16 DNA status.
RESULTS: ELISA results were in agreement in 97% (104/107) of paired sera and oral fluid. Of six women with positive anti-HPV16 serum samples, only three had positive oral fluid specimens. However, the specificity of the oral fluid test was 100% compared to the blood test.
CONCLUSIONS: Detection of antibodies in oral fluid correlated with antibodies but was less sensitive than sera. A larger validation study is required to fully characterize the oral fluid assay.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16316777     DOI: 10.1016/j.jcv.2005.09.014

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  7 in total

Review 1.  Human papillomavirus-related diseases: oropharynx cancers and potential implications for adolescent HPV vaccination.

Authors:  Maura L Gillison
Journal:  J Adolesc Health       Date:  2008-10       Impact factor: 5.012

Review 2.  The potential impact of prophylactic human papillomavirus vaccination on oropharyngeal cancer.

Authors:  Theresa Guo; David W Eisele; Carole Fakhry
Journal:  Cancer       Date:  2016-05-06       Impact factor: 6.860

3.  Antibody responses in oral fluid after administration of prophylactic human papillomavirus vaccines.

Authors:  Ali Rowhani-Rahbar; Joseph J Carter; Stephen E Hawes; James P Hughes; Noel S Weiss; Denise A Galloway; Laura A Koutsky
Journal:  J Infect Dis       Date:  2009-11-01       Impact factor: 5.226

4.  Evaluation of HPV-16 and HPV-18 specific antibody measurements in saliva collected in oral rinses and merocel® sponges.

Authors:  Katherine H Parker; Troy J Kemp; Yuanji Pan; Zhen Yang; Anna R Giuliano; Ligia A Pinto
Journal:  Vaccine       Date:  2018-04-06       Impact factor: 3.641

5.  More men than women make mucosal IgA antibodies to Human papillomavirus type 16 (HPV-16) and HPV-18: a study of oral HPV and oral HPV antibodies in a normal healthy population.

Authors:  Dianne J Marais; Candice Sampson; Anthea Jeftha; Dherendra Dhaya; Jo-Ann S Passmore; Lynette Denny; Edward P Rybicki; Eric Van Der Walt; Lawrence Xg Stephen; Anna-Lise Williamson
Journal:  BMC Infect Dis       Date:  2006-06-08       Impact factor: 3.090

Review 6.  Human Papillomavirus (HPV) virion induced cancer and subfertility, two sides of the same coin.

Authors:  C E Depuydt; J Beert; E Bosmans; G Salembier
Journal:  Facts Views Vis Obgyn       Date:  2016-12

7.  Adjustments for oral fluid quality and collection methods improve prediction of circulating tetanus antitoxin: Approaches for correcting antibody concentrations detected in a non-invasive specimen.

Authors:  Henri Garrison-Desany; Benard Omondi Ochieng; Maurice R Odiere; Helen Kuo; Dustin G Gibson; Joyce Were; E Wangeci Kagucia; Marcela F Pasetti; Hani Kim; Mardi Reymann; Katherine O'Brien; Kyla Hayford
Journal:  Vaccine       Date:  2020-11-27       Impact factor: 3.641

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.